lilly trials retatrutide ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Eli Lilly retatrutide Phase 3

Ozempic and Wegovy both contain semaglutide GLP-1, with Wegovy specifically approved for weight loss and Ozempic for managing type 2 diabetes

Side Effects Common (10%) Nausea, vomiting, diarrhea, constipation

This increased participation in active pursuits provides additional mental health benefits through exercise, nature exposure, and social connection

For women with type 2 diabetes who were taking GLP-1 medications before pregnancy, discontinuation is recommended before conception or as soon as pregnancy is confirmed

To build sustainable healthcare programs and employer benefit strategies, we have to design for the reality of clinical variance